U.S. Markets open in 7 hrs 14 mins
  • S&P Futures

    3,656.00
    +32.75 (+0.90%)
     
  • Dow Futures

    29,887.00
    +258.00 (+0.87%)
     
  • Nasdaq Futures

    12,397.00
    +120.00 (+0.98%)
     
  • Russell 2000 Futures

    1,842.30
    +22.20 (+1.22%)
     
  • Crude Oil

    45.08
    -0.26 (-0.57%)
     
  • Gold

    1,788.50
    +7.60 (+0.43%)
     
  • Silver

    22.92
    +0.39 (+1.71%)
     
  • EUR/USD

    1.1966
    +0.0031 (+0.2633%)
     
  • 10-Yr Bond

    0.8440
    0.0000 (0.00%)
     
  • Vix

    20.57
    -0.27 (-1.30%)
     
  • GBP/USD

    1.3384
    +0.0053 (+0.3962%)
     
  • USD/JPY

    104.3060
    -0.0180 (-0.0173%)
     
  • BTC-USD

    19,428.29
    -136.26 (-0.70%)
     
  • CMC Crypto 200

    382.09
    +17.49 (+4.80%)
     
  • FTSE 100

    6,266.19
    -101.39 (-1.59%)
     
  • Nikkei 225

    26,787.54
    +353.92 (+1.34%)
     

Navidea: 3Q Earnings Snapshot

·1 min read

DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Thursday reported a loss of $2.9 million in its third quarter.

The Dublin, Ohio-based company said it had a loss of 13 cents per share.

The biopharmaceutical posted revenue of $268,400 in the period. Its adjusted revenue was $268,000.

In the final minutes of trading on Thursday, the company's shares hit $2.21. A year ago, they were trading at 70 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NAVB at https://www.zacks.com/ap/NAVB